Literature DB >> 23168011

Screening for Fabry disease in patients with left ventricular hypertrophy.

Kazutoshi Mawatari, Hideo Yasukawa, Toyoharu Oba, Takanobu Nagata, Tadayasu Togawa, Takahiro Tsukimura, Sachiko Kyogoku, Hideki Ohshima, Tomoko Minami, Yusuke Sugi, Hitoshi Sakuraba, Tsutomu Imaizumi.   

Abstract

Entities:  

Keywords:  E66Q; Fabry disease; Functional polymorphism; Left ventricular hypertrophy; α-Galactosidase A

Mesh：

Substances：

Year:  2012        PMID： 23168011     DOI： 10.1016/j.ijcard.2012.10.076

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  6 in total

1.  Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis.

Authors:  Jiwon Seo; Minji Kim; Geu-Ru Hong; Dae-Seong Kim; Jang-Won Son; In Jeong Cho; Chi Young Shim; Hyuk-Jae Chang; Jong-Won Ha; Namsik Chung
Journal:  J Hum Genet       Date:  2016-05-26       Impact factor: 3.172

2.  Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease.

Authors:  Rodolfo Citro; Costantina Prota; Donatella Ferraioli; Giuseppe Iuliano; Michele Bellino; Ilaria Radano; Angelo Silverio; Serena Migliarino; Maria Vincenza Polito; Artemisia Ruggiero; Rosa Napoletano; Vincenzo Bellizzi; Michele Ciccarelli; Gennaro Galasso; Carmine Vecchione
Journal:  Front Cardiovasc Med       Date:  2022-04-25

3.  Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey.

Authors:  Hasan Ali Barman; Sevgi Özcan; Adem Atıcı; Caner Özgökçe; Ahmet Öztürk; Ayşegül Ezgi Kafalı; Nafiye Emel Çakar; Mustafa Emir Tavşanlı; Mehmet Küçük; Irfan Şahin; Ertuğrul Okuyan
Journal:  Anatol J Cardiol       Date:  2020-01       Impact factor: 1.596

Review 4.  Renal Manifestations of Fabry Disease: A Narrative Review.

Authors:  Cassiano Augusto Braga Silva; José A Moura-Neto; Marlene Antônia Dos Reis; Osvaldo Merege Vieira Neto; Fellype Carvalho Barreto
Journal:  Can J Kidney Health Dis       Date:  2021-01-19

5.  Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy.

Authors:  Martina Gaggl; Natalija Lajic; Georg Heinze; Till Voigtländer; Raute Sunder-Plassmann; Eduard Paschke; Günter Fauler; Gere Sunder-Plassmann; Gerald Mundigler
Journal:  Int J Med Sci       Date:  2016-04-26       Impact factor: 3.738

6.  Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy.

Authors:  Woo-Shik Kim; Hyun Soo Kim; Jinho Shin; Jong Chun Park; Han-Wook Yoo; Toshihiro Takenaka; Chuwa Tei
Journal:  J Korean Med Sci       Date:  2019-02-15       Impact factor: 2.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.